Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Poobalan Naidoo

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Case Reports in Medicine|October 4, 2011
Massive pulmonary thromboembolism and strokePoobalan Naidoo, Richard Hift
Orthopedic Research and Reviews|February 19, 2019
Viscosupplementation for knee osteoarthritis: a focus on Hylan G-F 20David Webb, Poobalan Naidoo
Southern Medical Journal|November 7, 2007
Dose-response relationships of sulfonylureas: will doubling the dose double the response?Virendra Rambiritch, Poobalan Naidoo, Neil Butkow
Clinical Pharmacology : Advances and Applications|April 18, 2014
Glibenclamide in patients with poorly controlled type 2 diabetes: a 12-week, prospective, single-center, open-label, dose-escalation studyVirendra Rambiritch, Breminand Maharaj, Poobalan Naidoo
Current Therapeutic Research, Clinical and Experimental|March 29, 2014
Effects of gliclazide dose escalation on postprandial hyperglycemia in type 2 diabetes mellitus: A prospective, open-label, case-controlled, dose-escalation studyPoobalan Naidoo, Rambiritch Virendra, Mayet Layla
Vascular Health and Risk Management|June 29, 2018
Paraoxonase (PON)-1: a brief overview on genetics, structure, polymorphisms and clinical relevanceNelusha Shunmoogam, Poobalan Naidoo, Robert Chilton
Clinical Pharmacology : Advances and Applications|October 8, 2016
Glibenclamide population pharmacokinetic/pharmacodynamic modeling in South African type 2 diabetic subjectsVirendra Rambiritch, Poobalan Naidoo, Goonaseelan Pillai
JMIR Research Protocols|August 6, 2016
Effect of Sitagliptin and Metformin on Prediabetes Progression to Type 2 Diabetes - A Randomized, Double-Blind, Double-Arm, Multicenter Clinical Trial: Protocol for the Sitagliptin and Metformin in PreDiabetes (SiMePreD) StudyPoobalan Naidoo, Jeffrey Wing, Virendra Rambiritch
JMIR Research Protocols|July 1, 2018
Therapeutic Management of Dyslipidemia Patients at Very High Cardiovascular Risk (CARDIO TRACK): Protocol for the Observational Registry StudyPoobalan Naidoo, Rashem Mothilal, Dirk Jacobus Blom
Clinical Pharmacology : Advances and Applications|July 30, 2016
Population pharmacokinetic modeling of glibenclamide in poorly controlled South African type 2 diabetic subjectsVirendra Rambiritch, Poobalan Naidoo, Breminand Maharaj, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Case Reports in Medicine|October 4, 2011
Massive pulmonary thromboembolism and strokePoobalan Naidoo, Richard Hift
Orthopedic Research and Reviews|February 19, 2019
Viscosupplementation for knee osteoarthritis: a focus on Hylan G-F 20David Webb, Poobalan Naidoo
Southern Medical Journal|November 7, 2007
Dose-response relationships of sulfonylureas: will doubling the dose double the response?Virendra Rambiritch, Poobalan Naidoo, Neil Butkow
Clinical Pharmacology : Advances and Applications|April 18, 2014
Glibenclamide in patients with poorly controlled type 2 diabetes: a 12-week, prospective, single-center, open-label, dose-escalation studyVirendra Rambiritch, Breminand Maharaj, Poobalan Naidoo
Current Therapeutic Research, Clinical and Experimental|March 29, 2014
Effects of gliclazide dose escalation on postprandial hyperglycemia in type 2 diabetes mellitus: A prospective, open-label, case-controlled, dose-escalation studyPoobalan Naidoo, Rambiritch Virendra, Mayet Layla
Vascular Health and Risk Management|June 29, 2018
Paraoxonase (PON)-1: a brief overview on genetics, structure, polymorphisms and clinical relevanceNelusha Shunmoogam, Poobalan Naidoo, Robert Chilton
Clinical Pharmacology : Advances and Applications|October 8, 2016
Glibenclamide population pharmacokinetic/pharmacodynamic modeling in South African type 2 diabetic subjectsVirendra Rambiritch, Poobalan Naidoo, Goonaseelan Pillai
JMIR Research Protocols|August 6, 2016
Effect of Sitagliptin and Metformin on Prediabetes Progression to Type 2 Diabetes - A Randomized, Double-Blind, Double-Arm, Multicenter Clinical Trial: Protocol for the Sitagliptin and Metformin in PreDiabetes (SiMePreD) StudyPoobalan Naidoo, Jeffrey Wing, Virendra Rambiritch
JMIR Research Protocols|July 1, 2018
Therapeutic Management of Dyslipidemia Patients at Very High Cardiovascular Risk (CARDIO TRACK): Protocol for the Observational Registry StudyPoobalan Naidoo, Rashem Mothilal, Dirk Jacobus Blom
Clinical Pharmacology : Advances and Applications|July 30, 2016
Population pharmacokinetic modeling of glibenclamide in poorly controlled South African type 2 diabetic subjectsVirendra Rambiritch, Poobalan Naidoo, Breminand Maharaj, et al.
Pageof 4